Trends in survival from primary central nervous system lymphoma, 1975-1999: a population-based analysis (Q44981082)

7 December 2017

title

Trends in survival from primary central nervous system lymphoma, 1975-1999: a population-based analysis (English)

1 reference

central nervous system lymphoma

7 December 2017

main subject

1 reference

primary central nervous system lymphoma

inferred from title

1 reference

Lauren E Abrey

1 reference

7 December 2017

Elena B Elkin

1 reference

7 December 2017

Katherine S Panageas

1 reference

7 December 2017

Lisa M DeAngelis

1 reference

7 December 2017

Leah Ben-Porat

series ordinal

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

7 December 2017

1 reference

7 December 2017

volume

104

1 reference

7 December 2017

1 reference

7 December 2017

page(s)

2466-2472

1 reference

Primary Central Nervous System Lymphoma

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21481

Survival improvement with combined radio-chemotherapy in the primary central nervous system lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21481

Accuracy of death certificates for coding coronary heart disease as the cause of death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21481

The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21481

7 January 2021

Increasing incidence of primary brain lymphoma in the US

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21481

7 January 2021

Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958-1989

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21481

7 January 2021

Primary central nervous system lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21481

7 January 2021

Primary CNS lymphoma: combined treatment with chemotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21481

7 January 2021

Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21481

7 January 2021

Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of radiation therapy oncology group protocol 88-06.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21481

7 January 2021

Primary central nervous system non-Hodgkin's lymphoma: survival advantages with combined initial therapy?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21481

7 January 2021

Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21481

7 January 2021

Treatment for primary CNS lymphoma: the next step

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21481

7 January 2021

Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21481

7 January 2021

Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21481

7 January 2021

Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21481

7 January 2021

Combined modality therapy for primary CNS lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21481

7 January 2021

German Cancer Society Neuro-Oncology Working Group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21481

7 January 2021

Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21481

7 January 2021

Combined-modality therapy in the treatment of primary central nervous system lymphoma in AIDS

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21481

7 January 2021

Influence of death certificate errors on cancer mortality trends

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21481

7 January 2021

Colorectal Cancer Deaths as Determined by Expert Committee and from Death Certificate

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21481

7 January 2021

Diversity in death certification: a case vignette approach

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21481

7 January 2021

The treatment of primary central nervous system lymphoma in 122 immunocompetent patients: a population-based study of successively treated cohorts from the British Colombia Cancer Agency

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21481

7 January 2021

Identifiers

DOI

10.1002/CNCR.21481

1 reference

7 December 2017

1 reference